Title | Type | SJR | H index | Total Docs. (2017) | Total Docs. (3years) | Total Refs. (2017) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2017) | %Female (2017) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.211 Q4 | 50 | 6 | 29 | 2272 | 29 | 22 | 0.70 | 378.67 | 0.00 | |
2 | Pharmacological Reviews | journal | 9.472 Q1 | 254 | 18 | 84 | 6360 | 1902 | 83 | 19.78 | 353.33 | 28.79 | |
3 | Medicinal Research Reviews | journal | 2.895 Q1 | 150 | 35 | 109 | 9057 | 1076 | 108 | 8.59 | 258.77 | 43.75 | |
4 | Advances in Molecular Toxicology | book series | 0.182 Q4 | 18 | 7 | 24 | 1294 | 13 | 0 | 0.29 | 184.86 | 0.00 | |
5 | Natural Product Reports | journal | 3.918 Q1 | 211 | 60 | 246 | 11057 | 2579 | 239 | 10.39 | 184.28 | 30.07 | |
6 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 0.573 Q2 | 82 | 16 | 44 | 2856 | 125 | 44 | 3.00 | 178.50 | 38.46 | |
7 | Pharmacology and Therapeutics | journal | 4.072 Q1 | 233 | 142 | 357 | 25171 | 3990 | 356 | 10.55 | 177.26 | 33.83 | |
8 | Reviews of Physiology Biochemistry and Pharmacology | journal | 1.463 Q1 | 70 | 3 | 25 | 524 | 109 | 17 | 3.65 | 174.67 | 0.00 | |
9 | Advanced Drug Delivery Reviews | journal | 4.090 Q1 | 366 | 155 | 508 | 26594 | 6936 | 464 | 13.03 | 171.57 | 34.75 | |
10 | Advances in Pharmacology | journal | 1.536 Q1 | 86 | 36 | 118 | 5802 | 440 | 0 | 3.46 | 161.17 | 0.00 | |
11 | Drug Metabolism Reviews | journal | 1.271 Q1 | 108 | 21 | 98 | 3158 | 491 | 97 | 4.10 | 150.38 | 40.43 | |
12 | Studies in Natural Products Chemistry | book series | 0.206 Q4 | 49 | 45 | 147 | 6577 | 144 | 27 | 0.78 | 146.16 | 0.00 | |
13 | Drug Resistance Updates | journal | 3.986 Q1 | 132 | 17 | 62 | 2472 | 756 | 62 | 12.40 | 145.41 | 44.78 | |
14 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.816 Q1 | 99 | 23 | 46 | 3288 | 324 | 45 | 6.97 | 142.96 | 46.84 | |
15 | Nano Today | journal | 7.191 Q1 | 175 | 46 | 184 | 6310 | 2543 | 134 | 13.47 | 137.17 | 29.17 | |
16 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 2 | 10 | 269 | 1 | 10 | 0.17 | 134.50 | 41.18 | ||
17 | Cancer Drug Discovery and Development | book series | 8 | 49 | 78 | 6519 | 12 | 51 | 0.18 | 133.04 | 18.75 | ||
18 | Annual Review of Pharmacology and Toxicology | journal | 6.718 Q1 | 224 | 28 | 91 | 3720 | 1264 | 90 | 13.97 | 132.86 | 23.26 | |
19 | Critical Reviews in Toxicology | journal | 1.828 Q1 | 129 | 36 | 124 | 4747 | 706 | 119 | 4.70 | 131.86 | 47.02 | |
20 | Topics in Medicinal Chemistry | book series | 0.244 Q3 | 15 | 22 | 75 | 2886 | 40 | 70 | 0.41 | 131.18 | 31.25 | |
21 | Current Medicinal Chemistry | journal | 1.015 Q2 | 202 | 284 | 873 | 35541 | 2862 | 815 | 3.32 | 125.14 | 42.59 | |
22 | Cellular and Molecular Life Sciences | journal | 3.388 Q1 | 261 | 280 | 923 | 33898 | 6350 | 909 | 6.93 | 121.06 | 42.13 | |
23 | Current Pharmaceutical Design | journal | 0.883 Q2 | 183 | 620 | 1828 | 74679 | 5143 | 1667 | 2.66 | 120.45 | 41.54 | |
24 | RSC Drug Discovery Series | book series | 0.210 Q3 | 13 | 52 | 243 | 6187 | 97 | 127 | 0.42 | 118.98 | 25.64 | |
25 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.760 Q2 | 52 | 27 | 83 | 3115 | 216 | 78 | 2.43 | 115.37 | 41.11 | |
26 | Current Neuropharmacology | journal | 1.210 Q1 | 103 | 83 | 241 | 9247 | 912 | 213 | 3.28 | 111.41 | 40.82 | |
27 | Expert Opinion on Emerging Drugs | journal | 1.109 Q2 | 54 | 28 | 129 | 3050 | 393 | 121 | 3.39 | 108.93 | 41.89 | |
28 | Current Pharmacology Reports | journal | 0.844 Q2 | 35 | 39 | 76 | 4191 | 237 | 76 | 3.12 | 107.46 | 41.18 | |
29 | Current Topics in Medicinal Chemistry | journal | 0.885 Q2 | 133 | 262 | 747 | 27685 | 2168 | 649 | 3.09 | 105.67 | 38.41 | |
30 | Progress in Medicinal Chemistry | journal | 1.253 Q1 | 38 | 5 | 17 | 525 | 60 | 4 | 2.75 | 105.00 | 0.00 | |
31 | Mini-Reviews in Medicinal Chemistry | journal | 0.567 Q2 | 107 | 115 | 399 | 12053 | 863 | 366 | 2.08 | 104.81 | 48.82 | |
32 | Current Drug Metabolism | journal | 0.833 Q2 | 122 | 103 | 228 | 10789 | 726 | 214 | 2.75 | 104.75 | 36.00 | |
33 | Expert Opinion on Drug Discovery | journal | 1.309 Q1 | 84 | 104 | 308 | 10857 | 1196 | 294 | 4.36 | 104.39 | 41.42 | |
34 | Handbook of Experimental Pharmacology | journal | 1.570 Q1 | 110 | 150 | 326 | 15468 | 1365 | 243 | 3.82 | 103.12 | 33.33 | |
35 | NTP Research Report Series | book series | 3 | 2 | 2 | 206 | 0 | 2 | 0.00 | 103.00 | 50.00 | ||
36 | Current Drug Targets | journal | 0.906 Q2 | 119 | 140 | 536 | 14215 | 1303 | 481 | 2.13 | 101.54 | 41.85 | |
37 | Expert Opinion on Therapeutic Targets | journal | 1.597 Q1 | 106 | 109 | 366 | 10784 | 1597 | 356 | 4.28 | 98.94 | 45.76 | |
38 | Pharmacognosy Reviews (discontinued) | journal | 1.120 Q1 | 68 | 22 | 63 | 2165 | 325 | 62 | 3.07 | 98.41 | 43.64 | |
39 | Current Gene Therapy | journal | 0.951 Q1 | 80 | 44 | 140 | 4205 | 309 | 131 | 2.13 | 95.57 | 41.06 | |
40 | British Journal of Pharmacology | journal | 2.603 Q1 | 244 | 347 | 1124 | 32371 | 6944 | 1101 | 6.60 | 93.29 | 41.25 | |
41 | Current Cancer Drug Targets | journal | 0.951 Q1 | 103 | 69 | 223 | 6431 | 569 | 204 | 2.18 | 93.20 | 44.49 | |
42 | Issues in Toxicology | book series | 0.110 Q4 | 18 | 35 | 169 | 3257 | 31 | 85 | 0.23 | 93.06 | 0.00 | |
43 | Neurotherapeutics | journal | 2.530 Q1 | 136 | 97 | 234 | 8875 | 1420 | 216 | 5.60 | 91.49 | 37.73 | |
44 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 46 | 5 | 70 | 447 | 173 | 70 | 2.58 | 89.40 | 20.83 | ||
45 | Nanotheranostics | journal | 32 | 32 | 0 | 2831 | 0 | 0 | 0.00 | 88.47 | 36.09 | ||
46 | Expert Opinion on Drug Delivery | journal | 1.432 Q1 | 133 | 118 | 425 | 10326 | 2289 | 410 | 5.32 | 87.51 | 44.83 | |
47 | Expert Opinion on Biological Therapy | journal | 1.117 Q1 | 102 | 144 | 478 | 12513 | 1578 | 460 | 3.66 | 86.90 | 36.80 | |
48 | Journal of Cardiovascular Development and Disease | journal | 32 | 22 | 70 | 1902 | 107 | 65 | 1.75 | 86.45 | 40.00 | ||
49 | Expert Opinion on Therapeutic Patents | journal | 0.926 Q2 | 88 | 102 | 326 | 8792 | 1000 | 323 | 2.79 | 86.20 | 41.87 | |
50 | Cancer Nanotechnology | journal | 1.168 Q1 | 36 | 10 | 22 | 861 | 101 | 20 | 3.29 | 86.10 | 34.88 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®